Skip to content

Follicular Fluid Raman Shifts and IVF Outcomes

The Correlation Between Follicular Fluid Raman Spectrum and Embryo Development in Infertile Patients With Polycystic Ovary Syndrome

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04838535
Enrollment
150
Registered
2021-04-09
Start date
2019-06-19
Completion date
2021-12-19
Last updated
2021-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IVF, Polycystic Ovary Syndrome

Brief summary

This study intends to collect about 150 cases of follicular fluid samples from PCOS and non-PCOS infertility patients undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) cycles (in clinical routines).We tend to detect Raman metabolic profile of the follicular fluid of the PCOS and non-PCOS groups, and find the correlation between the metabolic profile of the follicular fluid of PCOS patients and the oocyte quality, IVF outcome and subsequent embryo development are also under investigation. Metabolomics analysis was applied to look for markers of follicular fluid in PCOS patients, and further exploring data and strategies to improve the embryonic development potential and IVF outcome of PCOS patients.

Interventions

DIAGNOSTIC_TESTRaman spectrum

The wavelength of the follicular fluids were scaned by Raman spectrum

Sponsors

ShangHai Ji Ai Genetics & IVF Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* Patients fit the Rotterdam criteria for PCOS * Patients under IVF cycles

Exclusion criteria

* Patients with male factors infertility * Patients with fallopian tube factors infertility

Design outcomes

Primary

MeasureTime frameDescription
Difference between polycystic ovary syndrome and normal follicular fluids24 monthsRaman spectrum was applied and the Raman spectrum characteristic absorption peak can be revealed. PCA analysis was used to measure the degree of differential shifts.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026